Preclinical data suggests rinzimetostat may maintain effectiveness against resistance mutations that develop with existing ...
Enozertinib shows strong efficacy in advanced NSCLC with EGFR atypical mutations, entering Phase 3 trials in 2027. ORIC ...
BEAD broadband program signs its first New Mexico construction agreement as Kit Carson Electric Cooperative commits to fiber ...
My 81-year-old father-in-law sold the family home in July for $75,000. For context, this is in a small town in Illinois, and the house was purchased in 1972 for approximately $7,500. Will he owe ...